Upcoming Dividend • Jul 13
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 20 July 2026. Payment date: 11 August 2026. Trailing yield: 8.0%. Within top quartile of South Korean dividend payers (4.3%). Higher than average of industry peers (1.6%). Upcoming Dividend • Jun 22
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 29 June 2026. Payment date: 05 August 2026. Trailing yield: 7.8%. Within top quartile of South Korean dividend payers (4.2%). Higher than average of industry peers (1.4%). Declared Dividend • May 15
Dividend of ₩50.00 announced Shareholders will receive a dividend of ₩50.00. Ex-date: 29th June 2026 Payment date: 5th August 2026 Dividend yield will be 6.8%, which is higher than the industry average of 1.7%. Sustainability & Growth The dividend has increased by an average of 7.0% per year over the past 6 years. However, payments have been volatile during that time. New Risk • Apr 06
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 67% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Shareholders have been substantially diluted in the past year (67% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩36.1b market cap, or US$24.0m). Tillkännagivande • Mar 18
Chinyang Poly Urethane Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 13.1521 billion. Chinyang Poly Urethane Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 13.1521 billion.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 6,700,000
Price\Range: KRW 1963
Discount Per Security: KRW 13.741
Transaction Features: Rights Offering Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to ₩2,355, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 25% over the past three years. Tillkännagivande • Feb 20
Chinyang Poly Urethane Co.,Ltd, Annual General Meeting, Mar 10, 2026 Chinyang Poly Urethane Co.,Ltd, Annual General Meeting, Mar 10, 2026, at 08:00 Tokyo Standard Time. Location: auditorium, 85, segyosandan-ro, gyeonggi-do, pyeongtaek South Korea Valuation Update With 7 Day Price Move • Jan 09
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₩2,905, the stock trades at a trailing P/E ratio of 7.8x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 27% over the past three years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩200 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 08 April 2026. Trailing yield: 7.0%. Within top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.3%). New Risk • Dec 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Minor Risks High level of debt (45% net debt to equity). Share price has been volatile over the past 3 months (9.0% average weekly change). Market cap is less than US$100m (₩34.4b market cap, or US$23.4m). Valuation Update With 7 Day Price Move • Dec 01
Investor sentiment deteriorates as stock falls 24% After last week's 24% share price decline to ₩3,435, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 26% over the past three years. Tillkännagivande • Nov 29
Chinyang Poly Urethane Co.,Ltd has filed a Follow-on Equity Offering in the amount of KRW 19.162 billion. Chinyang Poly Urethane Co.,Ltd has filed a Follow-on Equity Offering in the amount of KRW 19.162 billion.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 6,700,000
Price\Range: KRW 2860
Transaction Features: Subsequent Direct Listing New Risk • Nov 15
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Minor Risks High level of debt (45% net debt to equity). Market cap is less than US$100m (₩45.2b market cap, or US$31.1m). Declared Dividend • Nov 13
Dividend of ₩200 announced Shareholders will receive a dividend of ₩200. Ex-date: 29th December 2025 Payment date: 8th April 2026 Dividend yield will be 5.6%, which is higher than the industry average of 1.7%. Sustainability & Growth The dividend has increased by an average of 16% per year over the past 6 years and payments have been stable during that time. The company's earnings per share (EPS) would need to decline by 25% to shift the payout ratio to a potentially unsustainable range, which is more than the 14% EPS decline seen over the last 5 years. Valuation Update With 7 Day Price Move • Oct 30
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩4,355, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 14% over the past three years. Upcoming Dividend • Jun 20
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 27 June 2025. Payment date: 06 August 2025. Payout ratio is a comfortable 68% but the company is not cash flow positive. Trailing yield: 6.2%. Within top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.7%). New Risk • Jun 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 11% per year over the past 5 years. Minor Risks High level of debt (45% net debt to equity). Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩40.1b market cap, or US$29.1m). Declared Dividend • May 29
Dividend of ₩50.00 announced Shareholders will receive a dividend of ₩50.00. Ex-date: 27th June 2025 Payment date: 6th August 2025 Dividend yield will be 6.2%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 20% per year over the past 5 years and payments have been stable during that time. The company's earnings per share (EPS) would need to decline by 25% to shift the payout ratio to a potentially unsustainable range, which is more than the 14% EPS decline seen over the last 5 years. Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment deteriorates as stock falls 28% After last week's 28% share price decline to ₩4,240, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total loss to shareholders of 23% over the past three years. Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to ₩6,030, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 14% over the past three years. Tillkännagivande • Feb 19
Chinyang Poly Urethane Co.,Ltd, Annual General Meeting, Mar 11, 2025 Chinyang Poly Urethane Co.,Ltd, Annual General Meeting, Mar 11, 2025, at 08:00 Tokyo Standard Time. Location: auditorium, 85, segyosandan-ro, gyeonggi-do, pyeongtaek South Korea Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩7,940, the stock trades at a trailing P/E ratio of 21.5x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 13% over the past three years. Upcoming Dividend • Dec 20
Upcoming dividend of ₩200 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 08 April 2025. Payout ratio is a comfortable 68% but the company is not cash flow positive. Trailing yield: 3.8%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%). New Risk • Dec 16
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (9.2% average weekly change). Market cap is less than US$100m (₩72.6b market cap, or US$50.5m). New Risk • Dec 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 11% per year over the past 5 years. Minor Risks High level of debt (45% net debt to equity). Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.2% average weekly change). Market cap is less than US$100m (₩78.7b market cap, or US$55.0m). Valuation Update With 7 Day Price Move • Dec 10
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩7,230, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 42% over the past three years. Valuation Update With 7 Day Price Move • Nov 25
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₩6,310, the stock trades at a trailing P/E ratio of 17.1x. Average trailing P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 56% over the past three years. Declared Dividend • Nov 23
Dividend of ₩200 announced Shareholders will receive a dividend of ₩200. Ex-date: 27th December 2024 Payment date: 8th April 2025 Dividend yield will be 3.5%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 25% per year over the past 5 years and payments have been stable during that time. The company's earnings per share (EPS) would need to decline by 25% to shift the payout ratio to a potentially unsustainable range, which is more than the 14% EPS decline seen over the last 5 years. New Risk • Nov 22
New minor risk - Financial position The company has a high level of debt. Net debt to equity ratio: 45% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 11% per year over the past 5 years. Minor Risks High level of debt (45% net debt to equity). Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₩78.5b market cap, or US$56.0m). New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩67.4b market cap, or US$51.2m). Upcoming Dividend • Jun 20
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 27 June 2024. Payment date: 08 August 2024. Payout ratio is a comfortable 64% but the company is not cash flow positive. Trailing yield: 4.0%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.6%). Declared Dividend • May 23
Dividend of ₩50.00 announced Shareholders will receive a dividend of ₩50.00. Ex-date: 27th June 2024 Payment date: 8th August 2024 Dividend yield will be 3.8%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (64% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 26% per year over the past 4 years and payments have been stable during that time. Earnings per share has grown by 20% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • Mar 18
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₩6,650, the stock trades at a trailing P/E ratio of 18.2x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 100% over the past three years. Reported Earnings • Mar 07
Full year 2023 earnings released: EPS: ₩366 (vs ₩349 in FY 2022) Full year 2023 results: EPS: ₩366 (up from ₩349 in FY 2022). Revenue: ₩54.5b (up 3.4% from FY 2022). Net income: ₩3.66b (up 4.9% from FY 2022). Profit margin: 6.7% (up from 6.6% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 18% per year. Upcoming Dividend • Dec 20
Upcoming dividend of ₩150 per share at 4.1% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 04 April 2024. Payout ratio is a comfortable 65% but the company is not cash flow positive. Trailing yield: 4.1%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%). New Risk • Dec 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.1% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.6% average weekly change). Profit margins are more than 30% lower than last year (5.8% net profit margin). Market cap is less than US$100m (₩65.9b market cap, or US$50.5m). Valuation Update With 7 Day Price Move • Nov 01
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩7,700, the stock trades at a trailing P/E ratio of 28.1x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 123% over the past three years. Valuation Update With 7 Day Price Move • Sep 18
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩6,570, the stock trades at a trailing P/E ratio of 24x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 136% over the past three years. New Risk • Aug 20
New major risk - Revenue and earnings growth Earnings have declined by 1.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.3% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (238% cash payout ratio). Profit margins are more than 30% lower than last year (5.3% net profit margin). Market cap is less than US$100m (₩51.6b market cap, or US$38.5m). Reported Earnings • Aug 19
Second quarter 2023 earnings released: EPS: ₩107 (vs ₩172 in 2Q 2022) Second quarter 2023 results: EPS: ₩107 (down from ₩172 in 2Q 2022). Revenue: ₩13.5b (down 5.9% from 2Q 2022). Net income: ₩1.07b (down 38% from 2Q 2022). Profit margin: 7.9% (down from 12% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩5,640, the stock trades at a trailing P/E ratio of 16.6x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 108% over the past three years. Upcoming Dividend • Jun 22
Upcoming dividend of ₩50.00 per share at 3.6% yield Eligible shareholders must have bought the stock before 29 June 2023. Payment date: 09 August 2023. Payout ratio is a comfortable 59% but the company is paying out more than the cash it is generating. Trailing yield: 3.6%. Within top quartile of South Korean dividend payers (3.2%). Higher than average of industry peers (1.5%). Reported Earnings • May 20
First quarter 2023 earnings released: EPS: ₩80.00 (vs ₩90.00 in 1Q 2022) First quarter 2023 results: EPS: ₩80.00 (down from ₩90.00 in 1Q 2022). Revenue: ₩13.7b (down 2.0% from 1Q 2022). Net income: ₩797.4m (down 12% from 1Q 2022). Profit margin: 5.8% (down from 6.5% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • May 03
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩5,820, the stock trades at a trailing P/E ratio of 16.7x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 133% over the past three years. Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to ₩5,190, the stock trades at a trailing P/E ratio of 14.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 126% over the past three years. Reported Earnings • Mar 09
Full year 2022 earnings released: EPS: ₩349 (vs ₩380 in FY 2021) Full year 2022 results: EPS: ₩349 (down from ₩380 in FY 2021). Revenue: ₩52.7b (flat on FY 2021). Net income: ₩3.49b (down 8.1% from FY 2021). Profit margin: 6.6% (down from 7.2% in FY 2021). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Upcoming Dividend • Dec 21
Upcoming dividend of ₩150 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 05 April 2023. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 4.3%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%). Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Jul 11
Investor sentiment improved over the past week After last week's 20% share price gain to ₩6,200, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 141% over the past three years. Valuation Update With 7 Day Price Move • Jun 23
Investor sentiment deteriorated over the past week After last week's 21% share price decline to ₩4,605, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 119% over the past three years. Upcoming Dividend • Jun 22
Upcoming dividend of ₩25.00 per share Eligible shareholders must have bought the stock before 29 June 2022. Payment date: 10 August 2022. Payout ratio is a comfortable 39% and this is well supported by cash flows. Trailing yield: 3.3%. Within top quartile of South Korean dividend payers (3.2%). Higher than average of industry peers (2.4%). Valuation Update With 7 Day Price Move • Jun 09
Investor sentiment improved over the past week After last week's 18% share price gain to ₩6,200, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 187% over the past three years. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Apr 11
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₩6,100, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 204% over the past three years. Reported Earnings • Mar 10
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: ₩380 (up from ₩161 in FY 2020). Revenue: ₩53.1b (up 43% from FY 2020). Net income: ₩3.80b (up 136% from FY 2020). Profit margin: 7.2% (up from 4.3% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 25%. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 55% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Dec 27
Investor sentiment improved over the past week After last week's 16% share price gain to ₩6,500, the stock trades at a trailing P/E ratio of 27.8x. Average trailing P/E is 17x in the Chemicals industry in South Korea. Total returns to shareholders of 210% over the past three years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩100.00 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 06 April 2022. Payout ratio is a comfortable 64% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%). Valuation Update With 7 Day Price Move • Dec 09
Investor sentiment improved over the past week After last week's 20% share price gain to ₩5,570, the stock trades at a trailing P/E ratio of 23.8x. Average trailing P/E is 17x in the Chemicals industry in South Korea. Total returns to shareholders of 182% over the past three years. Upcoming Dividend • Jun 22
Upcoming dividend of ₩25.00 per share Eligible shareholders must have bought the stock before 29 June 2021. Payment date: 13 August 2021. Trailing yield: 3.1%. Within top quartile of South Korean dividend payers (2.1%). Higher than average of industry peers (1.4%). Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment improved over the past week After last week's 16% share price gain to ₩4,615, the stock trades at a trailing P/E ratio of 28.7x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 189% over the past three years. Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment improved over the past week After last week's 16% share price gain to ₩4,205, the stock trades at a trailing P/E ratio of 26.1x. Average trailing P/E is 19x in the Chemicals industry in South Korea. Total returns to shareholders of 163% over the past three years. Reported Earnings • Mar 10
Full year 2020 earnings released: EPS ₩161 (vs ₩755 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ₩37.1b (up 5.7% from FY 2019). Net income: ₩1.61b (down 79% from FY 2019). Profit margin: 4.3% (down from 22% in FY 2019). The decrease in margin was driven by higher expenses. Is New 90 Day High Low • Feb 26
New 90-day low: ₩3,060 The company is down 12% from its price of ₩3,490 on 27 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. Tillkännagivande • Feb 25
Chinyang Poly Urethane Co.,Ltd, Annual General Meeting, Mar 16, 2021 Chinyang Poly Urethane Co.,Ltd, Annual General Meeting, Mar 16, 2021, at 08:00 Korea Standard Time. Valuation Update With 7 Day Price Move • Jan 29
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩3,095, the stock is trading at a trailing P/E ratio of 15.9x, down from the previous P/E ratio of 19x. This compares to an average P/E of 17x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 62%. Is New 90 Day High Low • Jan 29
New 90-day low: ₩3,095 The company is down 10.0% from its price of ₩3,455 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 39% over the same period. Is New 90 Day High Low • Jan 05
New 90-day high: ₩3,970 The company is up 20% from its price of ₩3,305 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 26% over the same period. Valuation Update With 7 Day Price Move • Oct 26
Market pulls back on stock over the past week After last week's 15% share price decline to ₩3,230, the stock is trading at a trailing P/E ratio of 4.5x, down from the previous P/E ratio of 5.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 80%. Valuation Update With 7 Day Price Move • Oct 15
Market bids up stock over the past week After last week's 21% share price gain to ₩3,920, the stock is trading at a trailing P/E ratio of 5.5x, up from the previous P/E ratio of 4.5x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 124%. Is New 90 Day High Low • Oct 12
New 90-day high: ₩3,405 The company is up 12% from its price of ₩3,045 on 14 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 30% over the same period.